Loading...
The merits of surgical versus medical therapy for gastroesophageal reflux disease are the subject of a long-standing debate between surgeons and gastroenterologists. In a recent clinical trial, long-term remission was achieved more often with surgery than with esomeprazole treatment, but a higher proportion of the surgically treated patients required additional proton-pump inhibitor (PPI) therapy (Br J Surg 2007; 94:198).
Researchers performed a randomized, open, parallel-group, multicenter trial that compared laparoscopic antireflux surgery (LARS) with medical therapy (esomeprazole) in 514 European patients whose GERD was diagnosed by endoscopy and 24-hour pH monitoring. After a 3-month run-in period with esomeprazole (40 mg daily) to verif…